(Press-News.org) Raymond N. DuBois, M.D., Ph.D., director of MUSC Hollings Cancer Center, has been inducted as a fellow into the Royal College of Physicians (RCP).
DuBois traveled to London, England, for the ceremony in July. He had been elected to the prestigious body prior to the COVID pandemic, which delayed the induction ceremony.
The Royal College of Physicians was established in 1518 by a royal charter from King Henry VIII. The college's founding aim was to professionalize physicians through an academic body that required a degree and an exam before entry. Today, the RCP seeks to "drive improvements in health and healthcare through advocacy, education and research." Fellows are senior clinicians who have demonstrated achievement and impact on the field of medicine.
DuBois said he was incredibly honored to be named a fellow. He was impressed, during the ceremony, by the breadth of physicians, from every discipline of clinical care, research and education and from across the world, who were being inducted alongside him.
“Medicine is a remarkably unifying discipline,” he said. “Across the globe, people are working together to figure out complex medical problems and share their knowledge and discoveries. They all want to improve the health of their populations and of patients everywhere. Sharing knowledge and expertise is the most energizing aspect of these gatherings.”
He noted that the dinner after the RCP induction ceremony was a bit of a full-circle moment for him.
“The dinner was held in the Osler Room, which has meaning to me since I was an Osler Resident at Johns Hopkins Hospital back in the 1990s,” he explained.
Originally from Canada, William Osler, M.D., is considered the father of modern medicine. He developed a medical training program at Hopkins that would be familiar to any medical student today and was also named a fellow of the RCP.
DuBois was named the director of Hollings in 2020, after serving as dean of the MUSC College of Medicine since 2016. DuBois is internationally known for his work studying the connection between inflammation and cancer. His lab is currently studying how dietary fats affect the development of colon cancer.
In addition to his work at Hollings, DuBois serves as the vice chair of the Scientific Advisory Committee for Stand Up 2 Cancer and the executive chairman of the board for The Mark Foundation for Cancer Research.
In 2019, he was elected to the National Academy of Medicine, and in 2022, the American Association for Cancer Research honored him with its Distinguished Service Award.
About MUSC Hollings Cancer Center
MUSC Hollings Cancer Center is South Carolina’s only National Cancer Institute-designated cancer center with the largest academic-based cancer research program in the state. The cancer center comprises more than 130 faculty cancer scientists and 20 academic departments. It has an annual research funding portfolio of more than $44 million and sponsors more than 200 clinical trials across the state. Dedicated to preventing and reducing the cancer burden statewide, the Hollings Office of Community Outreach and Engagement works with community organizations to bring cancer education and prevention information to affected populations. Hollings offers state-of-the-art cancer screening, diagnostic capabilities, therapies and surgical techniques within its multidisciplinary clinics. Hollings specialists include surgeons, medical oncologists, radiation oncologists, radiologists, pathologists, psychologists and other clinical providers equipped to provide the full range of cancer care. For more information, visit hollingscancercenter.musc.edu.
END
Hollings director honored as fellow of Royal College of Physicians
2023-07-31
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
NIH launches long COVID clinical trials through RECOVER Initiative, opening enrollment
2023-07-31
EMBARGOED FOR RELEASE
Monday, July 31, 2023
Noon EDT
Contact
NIH Office of Communications and Public Liaison
NIH News Media Branch
301-496-5787
NIH launches long COVID clinical trials through RECOVER Initiative, opening enrollment
Today, the National Institutes of Health launched and is opening enrollment for phase 2 clinical trials that will evaluate at least four potential treatments for long COVID, with additional clinical trials to test at least seven more treatments expected in the coming months. Treatments ...
Johnson-Matthews receives funding for conference: VL/HCC 2023 Graduate Consortium
2023-07-31
Brittany Johnson-Matthews, Assistant Professor, Computer Science, received funding from the National Science Foundation for: "Conference: VL/HCC 2023 Graduate Consortium."
This award will support the Graduate Consortium at this year's IEEE Conference on Visual Languages and Human-Centric Computing (VL/HCC), which will be held in Washington, D.C. October 2-6, 2023.
Johnson-Matthews said, "This funding will support the ability for students across the country to come together, network, share their research, and curate advice on completing their PhD from senior members of the VL/HCC community."
VL/HCC ...
Wang conducting finite temperature simulation of non-Markovian quantum dynamics
2023-07-31
Wang Conducting Finite Temperature Simulation Of Non-Markovian Quantum Dynamics
Fei Wang, Assistant Professor, Chemistry and Biochemistry, received funding from the National Science Foundation for the project: "Finite temperature simulation of non-Markovian quantum dynamics in condensed phase using quantum computers."
For this research, Wang will develop efficient quantum algorithms to perform condensed phase quantum dynamics simulations on quantum computers.
Many important physical and chemical processes occur in the condensed phase, spanning chemical reactions in solutions, charge transfer at semiconductor interfaces, ...
Study demonstrates efficacy of new short-term resistant TB treatment
2023-07-31
(Boston) – Tuberculosis (TB) disproportionately affects vulnerable populations including those with limited economic resources, HIV patients, those whose diet is deficient in nutrients and others. Resistant TB (MDR TB) does not respond to first line medications and is difficult to treat, requiring long regimens of 15-20 months that are associated with significant side effects and poor outcomes.
Recently, new six-month regimens have been shown to have better results than the long-term treatments, with improved quality of life and health equity. But these novel regimens have not yet been adopted widely in the United States. ...
The rise of bio-concrete (video)
2023-07-31
WASHINGTON, July 31, 2023 — Concrete is the most important building material on Earth, but its production causes a MASSIVE amount of global carbon emissions. Join George as he discovers how a surprising discovery in 1973 could dramatically change how we make concrete forever. https://youtu.be/fEt92F1c730
Reactions is a video series produced by the American Chemical Society and PBS Digital Studios. Subscribe to Reactions at http://bit.ly/ACSReactions and follow us on Twitter @ACSReactions.
The American Chemical Society (ACS) is a nonprofit organization chartered by the U.S. Congress. ACS’ ...
GPT-3 can reason about as well as a college student, UCLA psychologists report
2023-07-31
People solve new problems readily without any special training or practice by comparing them to familiar problems and extending the solution to the new problem. That process, known as analogical reasoning, has long been thought to be a uniquely human ability.
But now people might have to make room for a new kid on the block.
Research by UCLA psychologists shows that, astonishingly, the artificial intelligence language model GPT-3 performs about as well as college undergraduates when asked to solve the sort of reasoning problems that typically appear on intelligence tests and standardized tests such as the SAT. The study is published in Nature Human Behaviour.
But the paper’s authors ...
Associations of military-related traumatic brain injury with new-onset mental health conditions and suicide risk
2023-07-31
About The Study: In this study including 860,000 soldiers, rates of new-onset mental health conditions were higher among individuals with a history of military-related traumatic brain injury (TBI) compared with those without. Moreover, risk for suicide was both directly and indirectly associated with history of TBI.
Authors: Lisa A. Brenner, Ph.D., of the VHA Rocky Mountain Mental Illness Research Education and Clinical Center in Aurora, Colorado, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link ...
Association of racial and ethnic identity with attrition from M.D.-Ph.D. Training programs
2023-07-31
About The Study: This study found significant racial and ethnic disparities in attrition from M.D.-Ph.D. training, where Black students had greater than 50% higher odds of leaving M.D.-Ph.D. training than their peers. Notably, compared with 17% of white students, 29% of Black M.D.-Ph.D. students did not complete their training.
Authors: Mytien Nguyen, M.S., of the Yale School of Medicine in New Haven, Connecticut, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamainternmed.2023.2822)
Editor’s ...
Association between gestational age and academic achievement of children born at term
2023-07-31
About The Study: The findings of this study of more than 500,000 children suggest that there is no evidence of a difference in math and reading scores over grades 2 to 11 among children born between 39 and 40 weeks’ gestation, and overall no evidence of better scores among those born at 41 weeks’ gestation compared with 40 weeks’ gestation. The results can further inform decisions on delivery timing at term birth by offering insights into long-term associations of delivery timing with cognitive development and school achievement.
Authors: George L. Wehby, M.P.H., Ph.D., of ...
CABBI develops eco-friendly enzyme to create key chemical building blocks
2023-07-31
Using energy from light to activate natural enzymes can help scientists create new-to-nature enzymatic reactions that support eco-friendly biomanufacturing — the production of fuels, plastics, and valuable chemicals from plants or other biological systems.
Applying this photoenzymatic approach, researchers have developed a clean, efficient way to synthesize crucial chemical building blocks known as chiral amines, solving a longstanding challenge in synthetic chemistry.
The study, published in Nature Catalysis, ...